These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 15004439
21. Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Saibeni S, Bottasso B, Spina L, Bajetta M, Danese S, Gasbarrini A, de Franchis R, Vecchi M. Am J Gastroenterol; 2004 Oct; 99(10):1966-70. PubMed ID: 15447757 [Abstract] [Full Text] [Related]
22. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Oral B, Mermi B, Dilek M, Alanoğlu G, Sütçü R. Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106 [Abstract] [Full Text] [Related]
31. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Mosnier LO, Meijers JC, Bouma BN. Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587 [Abstract] [Full Text] [Related]
32. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN. Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321 [Abstract] [Full Text] [Related]
37. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever. Sonmez M, Aydin K, Durmus A, Sucu N, Yilmaz M, Akdogan E, Koksal I, Ovali E, Omay SB. J Infect; 2007 Aug; 55(2):184-7. PubMed ID: 17418898 [Abstract] [Full Text] [Related]
38. Plasma thrombin-activatable fibrinolysis inhibitor as an indicator of inflammation and disease severity in acute pancreatitis. Sayilir A, Beyazit Y, Yesil Y, Albayrak M, Ekiz F, Celik T, Suvak B, Torun S, Ibiş M. Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):498-504. PubMed ID: 22230218 [Abstract] [Full Text] [Related]